The Prevention Of WEight Regain in diabetes type 2 (POWER) study: the effectiveness of adding a combined psychological intervention to a very low calorie diet, design and pilot data of a randomized controlled trial

Kirsten A C Berk, Hanneke Buijks, Behiye Ozcan, Adriaan Van't Spijker, Jan J V Busschbach, Eric J G Sijbrands, Kirsten A C Berk, Hanneke Buijks, Behiye Ozcan, Adriaan Van't Spijker, Jan J V Busschbach, Eric J G Sijbrands

Abstract

Background: Obesity is of major pathogenetic importance to type 2 diabetes, it contributes to poor glycemic control and increases the risk of cardiovascular disease. Over 80% of patients with diabetes type 2 are overweight. To achieve a more favourable risk profile, changes in diet and lifestyle are needed. However, current treatment programs for obese DM type 2 patients are not effective in the long term. In this RCT, we compare the effectiveness of a Combined Psychological Intervention (CPI) and usual care in maintaining the favourable effects on weight and risk profile during 2 years of follow-up after a Very Low Calorie Diet (VLCD).

Methods and design: In a randomised parallel group intervention study, 140 patients with type 2 diabetes and overweight (BMI>27 kg/m2) will be recruited from the outpatient department of the Erasmus Medical Centre.After obtaining ≥5% of weight loss with a VLCD, participants will be randomly assigned to CPI or usual care for 10 weeks. CPI consists of cognitive behaviour therapy, problem solving therapy and proactive coping.Primary outcome measure is weight change (kg).Other outcome measures are Body Mass Index (BMI = weight (kg)/length (m)2), waist circumference (cm), systolic blood pressure (mmHg), HbA1c (mmol/mol), lipid levels (LDL, HDL, TG (mmol/l) and chol/HDL-ratio), antidiabetic agents and doses, cardiovascular risk profile (UKPDS), lifestyle and quality of life (EuroQol EQ-5D). Psychosocial parameters are also studied, as secondary outcomes as well as determinants for weight loss.When successful, we want to conduct an analysis of the cost effectiveness of the intervention as compared to usual care.

Discussion: We expect that a CPI after a VLCD will be effective in maintaining weight loss and improving cardiovascular risk and glycaemic control, while being cost-effective and improving quality of life in patients with type 2 diabetes.

Clinical trials registration: trialregister.nl NTR2264.

Figures

Figure 1
Figure 1
Flow chart of participants. VLCD = Very Low Calorie Diet; CPI = Combined Psychological Intervention.

References

    1. Roglic G, Unwin N. Mortality attributable to diabetes: estimates for the year 2010. Diabetes Res Clin Pract. 2010;87(1):15–29. doi: 10.1016/j.diabres.2009.10.006.
    1. Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med. 2003;348(5):383–393. doi: 10.1056/NEJMoa021778.
    1. Anderson JW, Kendall CW, Jenkins DJ. Importance of weight management in type 2 diabetes: review with meta-analysis of clinical studies. J Am Coll Nutr. 2003;22(5):331–339.
    1. Institute NHLaB. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: the evidence report. Washington DC: National Institutes of Health; 1998.
    1. Maggio CA, Pi-Sunyer FX. The prevention and treatment of obesity. Application to type 2 diabetes. Diabetes Care. 1997;20(11):1744–1766.
    1. Williamson DF, Thompson TJ, Thun M, Flanders D, Pamuk E, Byers T. Intentional weight loss and mortality among overweight individuals with diabetes. Diabetes Care. 2000;23(10):1499–1504. doi: 10.2337/diacare.23.10.1499.
    1. Norris SL, Zhang X, Avenell A, Gregg E, Brown TJ, Schmid CH, Lau J. Long-term non-pharmacologic weight loss interventions for adults with type 2 diabetes. Cochrane Database Syst Rev. 2005;18(2):CD004095.
    1. Wing RR. Use of very-low-calorie diets in the treatment of obese persons with non-insulin-dependent diabetes mellitus. J Am Diet Assoc. 1995;95(5):569–572. doi: 10.1016/S0002-8223(95)00155-7. quiz 573–564.
    1. Amatruda JM, Richeson JF, Welle SL, Brodows RG, Lockwood DH. The safety and efficacy of a controlled low-energy ('very-low-calorie') diet in the treatment of non-insulin-dependent diabetes and obesity. Arch Intern Med. 1988;148(4):873–877. doi: 10.1001/archinte.1988.00380040113017.
    1. Henry RR, Gumbiner B. Benefits and limitations of very-low-calorie diet therapy in obese NIDDM. Diabetes Care. 1991;14(9):802–823. doi: 10.2337/diacare.14.9.802.
    1. Capstick F, Brooks BA, Burns CM, Zilkens RR, Steinbeck KS, Yue DK. Very low calorie diet (VLCD): a useful alternative in the treatment of the obese NIDDM patient. Diabetes Res Clin Pract. 1997;36(2):105–111. doi: 10.1016/S0168-8227(97)00038-7.
    1. Jazet IM, Pijl H, Frolich M, Romijn JA, Meinders AE. Two days of a very low calorie diet reduces endogenous glucose production in obese type 2 diabetic patients despite the withdrawal of blood glucose-lowering therapies including insulin. Metabolism. 2005;54(6):705–712. doi: 10.1016/j.metabol.2004.12.015.
    1. Rotella CM, Cresci B, Mannucci E, Rizzello SM, Colzi G, Galli G, Giannini S, Messeri G, Piani F, Vannini R. et al.Short cycles of very low calorie diet in the therapy of obese type II diabetes mellitus. J Endocrinol Invest. 1994;17(3):171–179.
    1. Williams KV, Mullen ML, Kelley DE, Wing RR. The effect of short periods of caloric restriction on weight loss and glycemic control in type 2 diabetes. Diabetes Care. 1998;21(1):2–8. doi: 10.2337/diacare.21.1.2.
    1. Baker S, Jerums G, Proietto J. Effects and clinical potential of very-low-calorie diets (VLCDs) in type 2 diabetes. Diabetes Res Clin Pract. 2009;85(3):235–242. doi: 10.1016/j.diabres.2009.06.002.
    1. Dhindsa P, Scott AR, Donnelly R. Metabolic and cardiovascular effects of very-low-calorie diet therapy in obese patients with Type 2 diabetes in secondary failure: outcomes after 1 year. Diabet Med. 2003;20(4):319–324. doi: 10.1046/j.1464-5491.2003.00937.x.
    1. Paisey RB, Frost J, Harvey P, Paisey A, Bower L, Paisey RM, Taylor P, Belka I. Five year results of a prospective very low calorie diet or conventional weight loss programme in type 2 diabetes. J Hum Nutr Diet. 2002;15(2):121–127. doi: 10.1046/j.1365-277X.2002.00342.x.
    1. Wing RR, Marcus MD, Salata R, Epstein LH, Miaskiewicz S, Blair EH. Effects of a very-low-calorie diet on long-term glycemic control in obese type 2 diabetic subjects. Arch Intern Med. 1991;151(7):1334–1340. doi: 10.1001/archinte.1991.00400070100012.
    1. Jazet IM, de Craen AJ, van Schie EM, Meinders AE. Sustained beneficial metabolic effects 18 months after a 30-day very low calorie diet in severely obese, insulin-treated patients with type 2 diabetes. Diabetes Res Clin Pract. 2007;77(1):70–76. doi: 10.1016/j.diabres.2006.10.019.
    1. Shaw K, O'Rourke P, Del Mar C, Kenardy J. Psychological interventions for overweight or obesity. Cochrane Database Syst Rev. 2005;18(2):CD003818.
    1. Beck AT. Cognitive therapy and the emotional disorders. New York: International Universities Press; 1976.
    1. Fairburn C. A cognitive behavioural approach to the treatment of bulimia. Psychol Med. 1981;11(4):707–711. doi: 10.1017/S0033291700041209.
    1. Wilson GT, Fairburn CG. Cognitive treatments for eating disorders. J Consult Clin Psychol. 1993;61(2):261–269.
    1. Daansen PJ. Het obesitasprogramma: cognitieve gedragstherapie bij overgewicht. Den Haag: Parnassia; 2000.
    1. Block J. Effects of rational emotive therapy on overweight adults. Psychotherapy: Theory, Research and Practice. 1980;17(3):277–280.
    1. Cooper Z, Fairburn CG. A new cognitive behavioural approach to the treatment of obesity. Behav Res Ther. 2001;39(5):499–511. doi: 10.1016/S0005-7967(00)00065-6.
    1. Dennis KE, Pane KW, Adams BK, Qi BB. The impact of a shipboard weight control program. Obes Res. 1999;7(1):60–67. doi: 10.1002/j.1550-8528.1999.tb00391.x.
    1. Werrij MQ, Jansen A, Mulkens S, Elgersma HJ, Ament AJ, Hospers HJ. Adding cognitive therapy to dietetic treatment is associated with less relapse in obesity. J Psychosom Res. 2009;67(4):315–324. doi: 10.1016/j.jpsychores.2008.12.011.
    1. Ismail K, Winkley K, Rabe-Hesketh S. Systematic review and meta-analysis of randomised controlled trials of psychological interventions to improve glycaemic control in patients with type 2 diabetes. Lancet. 2004;363(9421):1589–1597. doi: 10.1016/S0140-6736(04)16202-8.
    1. D’Zurilla TJ, Nezu AM. In: Handbook of Cognitive Behavioral Therapies. 2. Dobson KS, editor. Guilford Press; 2001. Problem-solving Therapies; pp. 211–245.
    1. D'Zurilla TJ, Goldfried MR. Problem solving and behavior modification. J Abnorm Psychol. 1971;78(1):107–126.
    1. Mynors-Wallis LM, Gath DH, Day A, Baker F. Randomised controlled trial of problem solving treatment, antidepressant medication, and combined treatment for major depression in primary care. BMJ. 2000;320(7226):26–30. doi: 10.1136/bmj.320.7226.26.
    1. Mynors-Wallis LM, Gath DH, Lloyd-Thomas AR, Tomlinson D. Randomised controlled trial comparing problem solving treatment with amitriptyline and placebo for major depression in primary care. BMJ. 1995;310(6977):441–445. doi: 10.1136/bmj.310.6977.441.
    1. Perri MG, Nezu AM, Viegener BJ. Improving the long-term management of obesity: Theory, research and clinical guidelines. New York: Wiley; 1992.
    1. Perri MG, Nezu AM, McKelvey WF, Shermer RL, Renjilian DA, Viegener BJ. Relapse prevention training and problem-solving therapy in the long-term management of obesity. J Consult Clin Psychol. 2001;69(4):722–726.
    1. Murawski ME, Milsom VA, Ross KM, Rickel KA, DeBraganza N, Gibbons LM, Perri MG. Problem solving, treatment adherence, and weight-loss outcome among women participating in lifestyle treatment for obesity. Eat Behav. 2009;10(3):146–151. doi: 10.1016/j.eatbeh.2009.03.005.
    1. Aspinwall LG, Taylor SE. A stitch in time: self-regulation and proactive coping. Psychol Bull. 1997;121(3):417–436.
    1. Schwarzer R, Taubert S. In: Beyond Coping: Meeting Goals, Visions and Challenges. Fydenberg E, editor. London: Oxford University Press; 2002. Tenacious goal pursuits and striving toward personal growth: Proactive coping; pp. 19–35.
    1. Sohl SJ, Moyer A. Refining the Conceptualization of an Important Future-Oriented Self-Regulatory Behavior: Proactive Coping. Pers Individ Dif. 2009;47(2):139–144. doi: 10.1016/j.paid.2009.02.013.
    1. Thoolen B, De Ridder D, Bensing J, Maas C, Griffin S, Gorter K, Rutten G. Effectiveness of a self-management intervention in patients with screen-detected type 2 diabetes. Diabetes Care. 2007;30(11):2832–2837. doi: 10.2337/dc07-0777.
    1. Agras WS, Telch CF, Arnow B, Eldredge K, Marnell M. One-year follow-up of cognitive-behavioral therapy for obese individuals with binge eating disorder. J Consult Clin Psychol. 1997;65(2):343–347.
    1. Fairburn CG, Jones R, Peveler RC, Carr SJ, Solomon RA, O'Connor ME, Burton J, Hope RA. Three psychological treatments for bulimia nervosa. A comparative trial. Arch Gen Psychiatry. 1991;48(5):463–469. doi: 10.1001/archpsyc.1991.01810290075014.
    1. Fava GA, Ruini C, Rafanelli C, Finos L, Conti S, Grandi S. Six-year outcome of cognitive behavior therapy for prevention of recurrent depression. Am J Psychiatry. 2004;161(10):1872–1876. doi: 10.1176/appi.ajp.161.10.1872.
    1. Aberson CL. Applied power analysis for the behavioral sciences. New York: Routledge; 2010.
    1. Cohen J. Statistical power analysis for the behavioral sciences. New York: Academic; 1969.
    1. Fix B, Low W, Cockram DW. Effects of a liquid nutritional supplement containing a novel carbohydrate system on glucose tolerance in subjects with type 2 diabetes (abstract) Ann Nutr Metab. 2001;45(suppl 1):277.
    1. Gonzalez-Ortiz M, Martinez-Abundis E, Hernandez-Salazar E, Kam-Ramos AM, Robles-Cervantes JA. Effect of a nutritional liquid supplement designed for the patient with diabetes mellitus (Glucerna SR) on the postprandial glucose state, insulin secretion and insulin sensitivity in healthy subjects. Diabetes Obes Metab. 2006;8(3):331–335. doi: 10.1111/j.1463-1326.2005.00512.x.
    1. Sun J, Wang Y, Chen X, Chen Y, Feng Y, Zhang X, Pan Y, Hu T, Xu J, Du L. et integrated intervention program to control diabetes in overweight Chinese women and men with type 2 diabetes. Asia Pac J Clin Nutr. 2008;17(3):514–524.
    1. Stevens RJ, Kothari V, Adler AI, Stratton IM. United Kingdom Prospective Diabetes Study G. The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56) Clin Sci (Lond) 2001;101(6):671–679. doi: 10.1042/CS20000335.
    1. Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the hospital anxiety and depression scale. An updated literature review. J Psychosom Res. 2002;52(2):69–77. doi: 10.1016/S0022-3999(01)00296-3.
    1. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361–370. doi: 10.1111/j.1600-0447.1983.tb09716.x.
    1. Dirken JM. Arbeid en stress: het vaststellen van aanpassingsproblemen in werksituaties. Vragenlijst voor onderzoek van de ervaren gezondheidstoestand (VOEG) Wolters-Noordhoff; Leiden: Nederlands Instituut voor Praeventieve Geneeskunde TNO; 1969.
    1. Vercoulen J, Alberts M, Bleijenberg G. De Checklist Individual Strength (CIS) Gedragstherapie. 1999;32:131–136.
    1. Bultmann U, de Vries M, Beurskens AJ, Bleijenberg G, Vercoulen JH, Kant I. Measurement of prolonged fatigue in the working population: determination of a cutoff point for the checklist individual strength. J Occup Health Psychol. 2000;5(4):411–416.
    1. Rosenberg M. Society and The Adolescent Self-Image. Princeton, NJ: Princeton University Press; 1965.
    1. Fairburn CG, Beglin SJ. Assessment of eating disorders: interview or self-report questionnaire? Int J Eat Disord. 1994;16(4):363–370.
    1. Hafkenscheid A. The impact of psychotherapy sessions: internal structure of the Dutch Session Evaluation Questionnaire (SEQ) Psychol Psychother. 2009;82(Pt 1):99–111.
    1. Wendel-Vos GC, Schuit AJ, Saris WH, Kromhout D. Reproducibility and relative validity of the short questionnaire to assess health-enhancing physical activity. J Clin Epidemiol. 2003;56(12):1163–1169. doi: 10.1016/S0895-4356(03)00220-8.
    1. EuroQol--a new facility for the measurement of health-related quality of life. The EuroQol Group. Health Policy. 1990;16(3):199–208.
    1. Busschbach JJ, McDonnell J, Essink-Bot ML, van Hout BA. Estimating parametric relationships between health description and health valuation with an application to the EuroQol EQ-5D. J Health Econ. 1999;18(5):551–571. doi: 10.1016/S0167-6296(99)00008-9.
    1. IMTA. Vragenlijst over Zorggebruik, Ziekte en Werk (TIC-P) Rotterdam: Erasmus Medical Centre; 2007.
    1. Little RJA, Rubin DB. Statistical analysis with missing data. New York: John Wiley and Sons; 1987.
    1. Singer JD, Willett JB. Applied longitudinal data analysis - modeling change and event occurrence. Oxford: Oxford University Press; 2003.
    1. Verbeke G, Molenberghs G. Linear mixed models for longitudinal data. New York: Springer; 2000.
    1. Goodrick GK, Poston WS 2nd, Kimball KT, Reeves RS, Foreyt JP. Nondieting versus dieting treatment for overweight binge-eating women. J Consult Clin Psychol. 1998;66(2):363–368.

Source: PubMed

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

3
Sottoscrivi